GS
ABBV icon

GTS Securities’s AbbVie ABBV Stock Holding History

GTS Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Sell
6,393
-12,357
-66% -$2.74M 0.05% 282
2025
Q4 		$4.28M Buy
18,750
+10,631
+131% +$2.42M 0.15% 102
2025
Q3 		$1.88M Sell
8,119
-2,628
-24% -$535K 0.07% 215
2025
Q2 		$1.99M Sell
10,747
-9,792
-48% -$1.82M 0.09% 180
2025
Q1 		$4.3M Buy
20,539
+12,124
+144% +$2.36M 0.19% 77
2024
Q4 		$1.5M Sell
8,415
-14,907
-64% -$2.74M 0.07% 209
2024
Q3 		$4.61M Buy
23,322
+14,143
+154% +$2.64M 0.01% 947
2024
Q2 		$1.57M Buy
9,179
+6,515
+245% +$1.08M ﹤0.01% 1693
2024
Q1 		$485K Sell
2,664
-92,364
-97% -$15.9M ﹤0.01% 2610
2023
Q4 		$14.7M Buy
95,028
+81,506
+603% +$11.9M 0.03% 448
2023
Q3 		$2.02M Buy
+13,522
New +$1.99M ﹤0.01% 1512

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GTS Securities's ABBV Position: Q1 2026 in Review

GTS Securities reduced its AbbVie (ABBV) stake by 66% in Q1 2026, selling an estimated $2.74M and leaving 6,393 shares worth $1.39M. The position accounts for 0.05% of the portfolio, ranked #282.

GTS Securities first reported a position in ABBV in Q3 2023 and has held it in 11 quarters since. The position peaked at $14.7M in Q4 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • GTS Securities held 6,393 shares of AbbVie worth $1.39M as of Q1 2026.
  • GTS Securities sold 12,357 AbbVie shares in Q1 2026, an estimated $2.74M.
  • AbbVie made up 0.05% of GTS Securities's portfolio in Q1 2026, its #282 holding.
  • GTS Securities first reported a position in AbbVie in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's AbbVie position peaked at $14.7M in Q4 2023.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.